Interim report for Q1 2021
Continued high activity in the first quarter – infection prevention a global sustainability issueFirst quarter (January-March 2021) · Revenues amounted to SEK 41.8 (48.1) million, a decrease by 13%. Adjusted for currencies the decrease was 3%. · EBITDA amounted to SEK 1.9 (14.4) million with an EBITDA-margin of 5% (30%). · Operating profit amounted to SEK -9.7 (3.9) million. · Net loss for the period amounted to SEK -10.5 (-11.2) million. Earnings per share amounted to SEK -0.31 (-0.34). · Cash flow from operating activities amounted to SEK -0.9 (-3.5) million corresponding